In a week that will see a change of UK Prime Minister, I was delighted to be able to provide a positive and optimistic boost for the UK economy in launching a joint report with the Alliance of Regenerative Medicines, titled Leading Innovation: The UK’s ATMP landscape, which shows the UK’s globally leading position in advanced therapies, which includes the development of potentially transformative cell and gene therapies.
This year marked our 19th Annual Parliament Day event, which brings BIA members from across the sector to meet with parliamentarians, senior NHS leaders and civil servants from the Department for Business, Energy and Industrial Strategy and HM Treasury. As our flagship influencing event, Parliament Day facilitates important interactions between BIA members and policymakers across Westminster and Whitehall.
Cell and gene therapies and tissue-engineered products have the potential to offer a durable, life-changing effect, possibly with single administration
New report from Alliance for Regenerative Medicine and UK BioIndustry Association highlights progress in financing and clinical trials
24% of Europe’s ATMP developers headquartered in the UK
Last week we held our 19th annual BIA Parliament Day, bringing over 30 biotech sector leaders to Westminster to meet MPs, civil servants and NHS senior leadership. It was a great opportunity to highlight the value of the sector to key senior stakeholders and also for our members to learn more about what is going on in the machinery of government. Thank you to all members who helped make it such a success.
Today, as the BIA brings senior representatives from across the UK’s life sciences sector to meet with parliamentarians and civil servants for our annual Parliament Day, we thought we’d take a look at another key way we engage with Parliament – the All Party-Parliamentary Group (APPG) for Life Sciences.
Invest Newcastle has welcomed a senior Cuban life science business delegation to the region for a two-day visit. They used this opportunity to show off the city’s life science strengths and world-leading universities.
On the 17 September 2019, the BIA will be hosting its Regulatory Innovation Conference at 30 Euston Square.
The conference will explore the UK’s global capability for clinical trials, how we bring innovative medicines to market, evidence generation in support of regulatory decision-making and looking to the future, and what will the role of the regulator be as part of the global innovation ecosystem?
Arecor Limited, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a further collaboration with a major global pharmaceutical company.